Patents by Inventor Maria Ramirez Gonzalez

Maria Ramirez Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210401862
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Application
    Filed: September 13, 2021
    Publication date: December 30, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: ENRIQUE VAZQUEZ HERNANDEZ, RICARDO RUEDA CABRERA, RACHAEL BUCK, MARIA RAMIREZ GONZALEZ
  • Patent number: 11116779
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: September 14, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Enrique Vazquez Hernandez, Ricardo Rueda Cabrera, Rachael Buck, Maria Ramirez Gonzalez
  • Publication number: 20190381077
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Application
    Filed: August 30, 2019
    Publication date: December 19, 2019
    Applicant: ABBOTT LABORATORIES
    Inventors: ENRIQUE VAZQUEZ HERNANDEZ, RICARDO RUEDA CABRERA, RACHAEL BUCK, MARIA RAMIREZ GONZALEZ
  • Patent number: 10398716
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: September 3, 2019
    Assignee: ABBOTT LABORATORIES
    Inventors: Enrique Vazquez Hernandez, Ricardo Rueda Cabrera, Rachael Buck, Maria Ramirez Gonzalez
  • Patent number: 10398715
    Abstract: Disclosed are methods for enhancing learning and/or memory, enhancing memory acquisition, memory retention and recall by inducing a higher long-term potentiation in hippocampal neuronal synapsis in individuals. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: September 3, 2019
    Assignee: ABBOTT LABORATORIES
    Inventors: Enrique Vazquez Hernandez, Ricardo Rueda Cabrera, Rachael Buck, Maria Ramirez Gonzalez, Alejandro Barranco Perez
  • Publication number: 20160250169
    Abstract: Compositions including a combination of a source of choline, a source of magnesium, and a source of L-tryptophan are provided for improving cognitive performance in a subject. The compositions may improve a cognitive impairment and/or brain dysfunction associated with age-related cognitive decline or cognitive decline resulting from a neurodegenerative disease. The compositions may also be effective in improving memory acquisition, memory retention, and recall.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 1, 2016
    Applicant: Abbott Laboratories
    Inventors: Alejandro Barranco Perez, Enrique Vazquez Hernandez, Maria Ramirez Gonzalez, Ricardo Rueda Cabrera
  • Patent number: 9326956
    Abstract: Disclosed are methods for enhancing neural function in an individual, such as an older adult. The methods include administering nutritional compositions comprising HMB to the individual. The nutritional compositions provide benefits for individuals that have or may be at risk of having cognitive decline, cognitive impairment, and neural dysfunction, typically resulting from cognitive diseases associated with neurodegenerative diseases.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: May 3, 2016
    Assignee: Abbott Laboratories
    Inventors: Jose Maria Lopez Pedrosa, Manuel Manzano Martin, Alejandro Barranco Perez, Maria Ramirez Gonzalez, Ricardo Rueda Cabrera
  • Publication number: 20160022710
    Abstract: Disclosed are prenatal and lactation supplements for pregnant women and lactating women, which include a combination of RRR-alpha-tocopherol, docosahexaenoic acid (DHA), trans-lutein, phospholipids, and at least one nuclear receptor activating ligand other than RRR-alpha-tocopherol, DHA, and trans-lutein. The supplements may enhance central nervous system development in a fetus or breast-feeding newborn infant.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Applicant: ABBOTT LABORATORIES
    Inventors: Chron-Si Lai, Tama Bloch, Christina Sherry, Maria Ramirez Gonzalez, Matthew Kuchan, Gary Katz, Elena Oliveros Delgado, Angela Santos
  • Publication number: 20150238508
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 27, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: Enrique Vazquez Hernandez, Ricardo Rueda Cabrera, Rachael Buck, Maria Ramirez Gonzalez
  • Publication number: 20150231159
    Abstract: Disclosed are methods for enhancing learning and/or memory, enhancing memory acquisition, memory retention and recall by inducing a higher long-term potentiation in hippocampal neuronal synapsis in individuals. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Application
    Filed: September 12, 2013
    Publication date: August 20, 2015
    Applicant: ABBOTT LABORATORIES
    Inventors: Enrique Vazquez Hernandez, Ricardo Rueda Cabrera, Rachael Buck, Maria Ramirez Gonzalez, Alejandro Barranco Perez
  • Publication number: 20140249223
    Abstract: Disclosed are methods for enhancing neural function in an individual, such as an older adult. The methods include administering nutritional compositions comprising HMB to the individual. The nutritional compositions provide benefits for individuals that have or may be at risk of having cognitive decline, cognitive impairment, and neural dysfunction, typically resulting from cognitive diseases associated with neurodegenerative diseases.
    Type: Application
    Filed: February 13, 2012
    Publication date: September 4, 2014
    Applicant: ABBOTT LABORATORIES
    Inventors: Jose Maria Lopez Pedrosa, Manuel Manzano Martin, Alejandro Barranco Perez, Maria Ramirez Gonzalez, Ricardo Rueda Cabrera
  • Publication number: 20120270766
    Abstract: Disclosed are methods for improving memory and/or cognition in an infant by administering soy protein to the infant's mother during pregnancy, and further administering soy protein to the infant after delivery. The soy protein may be administered to the infant's mother during lactation if the infant is breastfed and/or may be directly administered, for example, by administering the infant an infant and/or nutritional formula comprising soy protein. Also disclosed are compositions comprising soy protein that may be used in the methods.
    Type: Application
    Filed: June 21, 2011
    Publication date: October 25, 2012
    Applicant: ABBOTT LABORATORIES
    Inventors: Ricardo Rueda Cabrera, Alejandro Barranco Perez, Maria Ramirez Gonzalez, Maria Jesus Martin